BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12894508)

  • 1. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of taurolidine on brain tumor cells.
    Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
    Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
    Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
    Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
    J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
    Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
    Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
    Perabo FG; Kamp S; Schmidt D; Lindner H; Steiner G; Mattes RH; Wirger A; Pegelow K; Albers P; Kohn EC; von Ruecker A; Mueller SC
    Br J Cancer; 2001 May; 84(10):1330-8. PubMed ID: 11355943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
    Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
    Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
    Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
    Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.
    Han Z; Ribbizi I; Pantazis P; Wyche J; Darnowski J; Calabresi P
    Anticancer Res; 2002; 22(4):1959-64. PubMed ID: 12174870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways.
    Duque G; El Abdaimi K; Henderson JE; Lomri A; Kremer R
    Bone; 2004 Jul; 35(1):57-64. PubMed ID: 15207741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress.
    Xia S; Rosen EM; Laterra J
    Cancer Res; 2005 Jun; 65(12):5248-55. PubMed ID: 15958570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells.
    Morais C; Westhuyzen J; Metharom P; Healy H
    Nephrol Dial Transplant; 2005 Jan; 20(1):50-8. PubMed ID: 15522900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.
    Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
    Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
    Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.